Acotec Scientific Holdings Limited

As of December 31, 2025, Acotec Scientific Holdings Limited carries a market capitalization of 460.88M, placing it among publicly traded companies globally. Its enterprise value stands at 375.24M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Acotec Scientific Holdings Limited's next confirmed earnings release is scheduled for March 29, 2027.

As of December 31, 2025, Acotec Scientific Holdings Limited has 313.39M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Acotec Scientific Holdings Limited maintains a current ratio of 5.73, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Acotec Scientific Holdings Limited's stock has declined approximately 53.96% over the past 52 weeks. The 50-day moving average sits at 0.69, while the 200-day moving average is 1.04.

As of December 31, 2025, Acotec Scientific Holdings Limited holds 115.38M in cash and equivalents against 29.75M in total debt, resulting in a net debt position of -40.36M. Total book value stands at 179.66M, with working capital of 134.32M providing operational flexibility.